Evidence map›Paper›PMID 25712214›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Liver-resident CD103+ dendritic cells prime antiviral CD8+ T cells in situ.

Peter D Krueger, Taeg S Kim, Sun-Sang J Sung, Thomas J Braciale, Young S Hahn

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 42 citations in OpenAlex.

  1. TLR9-independent CD8Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. The Liver and the Hepatic Immune Response inPathogens (Basel, Switzerland) · 2021
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Impact of anatomic site on antigen-presenting cells in cancer.Journal for immunotherapy of cancer · 2020
    Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. CXCells · 2019
    Article
  17. Review
  18. Infectious Sporozoites ofFrontiers in immunology · 2018
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Peter D KruegerBeirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908; Department of Microbiology, University of Virginia, Charlottesville, VA 22908;
Taeg S KimBeirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908; Department of Pathology, University of Virginia, Charlottesville, VA 22908; and.
Sun-Sang J SungBeirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908; Department of Medicine, Center for Immunity, Inflammation and Regenerative Medicine, University of Virginia, Charlottesville, VA 22908.
Thomas J BracialeBeirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908; Department of Pathology, University of Virginia, Charlottesville, VA 22908; and.
Young S HahnBeirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908; Department of Microbiology, University of Virginia, Charlottesville, VA 22908; ysh5e@virginia.edu.
University of Virginia · USCarter Center · US

Funding

Regulation of CD8+ T cell responses via liver NK-DC crosstalkU19AI083024 · NIAID · UNIVERSITY OF VIRGINIA · PI BRACIALE, THOMAS J · 2009 to 2013
$8.1M
Role of NK in Regulation of anti-viral T cell immunityR01DK063222 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HAHN, YOUNG S. · 2003 to 2011
$2.0M
Role of HCV in aberrant APC activation/functionR01AI098126 · NIAID · UNIVERSITY OF VIRGINIA · PI HAHN, YOUNG S. · 2012 to 2016
$1.9M
NIAID NIH HHS R01 AI098126NIAID NIH HHS U19 AI083024NIAID NIH HHS U19AI083024NIDDK NIH HHS DK063222NIDDK NIH HHS R01 DK063222
6 · The paper itself

Abstract

The liver maintains a tolerogenic environment to avoid unwarranted activation of its resident immune cells upon continuous exposure to food and bacterially derived Ags. However, in response to hepatotropic viral infection, the liver's ability to switch from a hyporesponsive to a proinflammatory environment is mediated by select sentinels within the parenchyma. To determine the contribution of hepatic dendritic cells (DCs) in the activation of naive CD8(+) T cells, we first characterized resident DC subsets in the murine liver. Liver DCs exhibit unique properties, including the expression of CD8α (traditionally lymphoid tissue specific), CD11b, and CD103 markers. In both the steady-state and following viral infection, liver CD103(+) DCs express high levels of MHC class II, CD80, and CD86 and contribute to the high number of activated CD8(+) T cells. Importantly, viral infection in the Batf3(-/-) mouse, which lacks CD8α(+) and CD103(+) DCs in the liver, results in a 3-fold reduction in the proliferative response of Ag-specific CD8(+) T cells. Limiting DC migration out of the liver does not significantly alter CD8(+) T cell responsiveness, indicating that CD103(+) DCs initiate the induction of CD8(+) T cell responses in situ. Collectively, these data suggest that liver-resident CD103(+) DCs are highly immunogenic in response to hepatotropic viral infection and serve as a major APC to support the local CD8(+) T cell response. It also implies that CD103(+) DCs present a promising cellular target for vaccination strategies to resolve chronic liver infections.

Indexed as

AdenoviridaeAnimalsAntigen-Presenting CellsAntigens, CDAntigens, SurfaceCD11b AntigenCD8-Positive T-LymphocytesCell MovementDendritic CellsFemaleImmunophenotypingIntegrin alpha ChainsLiverLymphocyte ActivationMaleMicealpha E integrinsAntigens, CDAntigens, SurfaceCD11b AntigenIntegrin alpha Chains

Identifiers

PMID25712214
PMCPMC4369411
OpenAlexW1840574375

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.